5-78984965-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000046.5(ARSB):c.284G>A(p.Arg95Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000537 in 1,488,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R95W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000046.5 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 6Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARSB | NM_000046.5 | c.284G>A | p.Arg95Gln | missense_variant | Exon 1 of 8 | ENST00000264914.10 | NP_000037.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARSB | ENST00000264914.10 | c.284G>A | p.Arg95Gln | missense_variant | Exon 1 of 8 | 1 | NM_000046.5 | ENSP00000264914.4 | ||
| ARSB | ENST00000396151.7 | c.284G>A | p.Arg95Gln | missense_variant | Exon 2 of 8 | 1 | ENSP00000379455.3 | |||
| ARSB | ENST00000565165.2 | c.284G>A | p.Arg95Gln | missense_variant | Exon 1 of 5 | 1 | ENSP00000456339.2 | |||
| ARSB | ENST00000521117.1 | c.*147G>A | downstream_gene_variant | 3 | ENSP00000428611.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151696Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000678 AC: 1AN: 147456 AF XY: 0.0000119 show subpopulations
GnomAD4 exome AF: 0.00000524 AC: 7AN: 1336738Hom.: 0 Cov.: 31 AF XY: 0.00000755 AC XY: 5AN XY: 662560 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151696Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74062 show subpopulations
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 6 Pathogenic:4
Variant summary: ARSB c.284G>A (p.Arg95Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-06 in 147456 control chromosomes. c.284G>A has been reported in the literature in compound heterozygous individuals affected with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome) (Litjens_1996, Invitae). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in almost loss of protein expression and enzymatic activity (Litjens_1996). The following publication have been ascertained in the context of this evaluation (PMID: 8651289). ClinVar contains an entry for this variant (Variation ID: 884). Based on the evidence outlined above, the variant was classified as pathogenic. -
In vitro functional studies supportive of a damaging effect on the gene product (low to no ARSB activity in homozygotes; PS3); Very low frequency in ExAc (PM2); Reputable source identifies as pathogenic (PP5) -
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 95 of the ARSB protein (p.Arg95Gln). This variant is present in population databases (rs118203942, gnomAD 0.001%). This missense change has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 8651289; Invitae). ClinVar contains an entry for this variant (Variation ID: 884). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSB protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ARSB function (PMID: 8651289). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at